drugset / Trial / NCT00006208

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

NCT00006208

Phase 3 Unknown Triangle Pharmaceuticals
Double-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of emtricitabine and stavudine when given with didanosine plus efavirenz to HIV-infected patients.

Timeline

Start
2000-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified
Subject emtricitabine Other / unclassified
Background Didanosine Small molecule
Background Efavirenz Other / unclassified